Sign in

You're signed outSign in or to get full access.

John Marren

Director at ADVANCED MICRO DEVICESADVANCED MICRO DEVICES
Board

About John W. Marren

Independent director of AMD since February 2017; age 62. Vice Chairman, North America at Temasek since November 2017; prior senior leadership across private equity (TPG Capital), investment banking (Morgan Stanley), sell-side research (Alex. Brown), and semiconductor operating roles (VLSI Technology, Vitesse). Holds a B.S. in Electrical Engineering from UC Santa Barbara; tenure on AMD’s board exceeds eight years, with capital markets and technology domain expertise cited by AMD’s Nominating & Corporate Governance Committee .

Past Roles

OrganizationRoleTenureCommittees/Impact
TemasekVice Chairman, North AmericaNov 2017–present Global investor leadership; tech and capital markets perspective
TPG CapitalSenior Partner; Head of Technology Investments2000–Dec 2015 Technology investing and portfolio governance
Morgan StanleyManaging Director; Co-Head, Tech Investment Banking1996–2000 Advisory and capital markets execution in semis/tech
Alex. Brown & SonsManaging Director; Senior Semiconductor Research Analyst1992–1996 Institutional Investor All-American Research Team member
VLSI Technology; Vitesse SemiconductorSemiconductor operating roles7 years pre-1992 Product/industry operating foundation

External Roles

OrganizationRoleTenureNotes
Impossible Foods (private)DirectorCurrent Food-tech governance
Eastdil Secured (private)DirectorCurrent Financial services governance
Creative Artists Agency (private)DirectorCurrent Media/entertainment governance
UC Santa BarbaraTrusteeCurrent Academic board service
U.S. Olympic & Paralympic FoundationBoard memberCurrent Non-profit oversight
Poshmark, Inc. (public)Director2018–2022 Former public company directorship

Board Governance

  • Committee assignments: Member, Audit & Finance Committee; committee held eight meetings in 2024; members are financially literate and independent per SEC/Nasdaq; audit committee financial expert designation applies to Householder and Olson (Marren is not designated as financial expert) .
  • Independence: Board determined all nominees other than Dr. Lisa Su are independent; no material transactions/relationships interfering with independent judgment; all committees (Audit & Finance, Nominating & Corporate Governance, Compensation) comprise independent directors .
  • Attendance: Board held eight meetings in 2024; all directors attended at least 75% of board and committee meetings; eight executive sessions of non-employee directors were held .
  • Lead Independent Director: Nora Denzel serves as Lead Independent Director (Marren is not in that role) .

Fixed Compensation

ComponentAmountDetail
Annual cash retainer$100,000 Standard non-employee director retainer
Committee membership (Audit & Finance)$20,000 Annual fee for Audit & Finance Committee service
Committee chair fee$0 Not a committee chair
Fees earned in cash (2024)$120,000 Summarized in director compensation table

Performance Compensation

Equity AwardGrant DateRSUs (#)Grant-Date Fair Value ($)VestingDeferral ElectionChange-of-Control Treatment
Annual RSU Award5/8/20241,547 $237,650 Vests on one-year anniversary Elected to defer issuance until leaving board All non-employee director equity fully vests upon change of control; also upon death/disability/retirement (≥3 years of service and guideline compliance)

AMD pays non-employee directors with a mix of cash and time-based RSUs (no performance metrics tied to director equity); RSU value formula uses a $250,000 target divided by 30-day average price (Chair receives 1.5x) .

Other Directorships & Interlocks

  • Current public company boards: No current public company directorships disclosed for Marren in the proxy; prior public service includes Poshmark, Inc. (2018–2022) .
  • Compensation Committee interlocks: AMD discloses no interlocks involving its Compensation Committee; Marren is not a member of the Compensation Committee in 2024 .

Expertise & Qualifications

  • Financial management, technology investing, and capital markets expertise; semiconductor industry operating experience; recognized as a top research analyst; EE degree from UC Santa Barbara .

Equity Ownership

MetricValue
Shares beneficially owned56,876
RSUs vesting within 60 days of 3/19/20251,547
Deferred RSU Shares (issuance deferred until board departure)55,329
Stock options held (as of FY-end)None
Ownership as % of shares outstanding0.0035% (56,876 / 1,616,297,522)
Compliance with director stock ownership guidelinesAll non-employee directors either met guidelines or had time remaining to comply as of 12/28/2024
  • Anti-hedging/pledging: AMD prohibits hedging; pledging requires Nominating & Governance pre-approval (none granted to date; none pledged by directors) .

Governance Assessment

  • Board effectiveness: Marren adds deep capital markets and semiconductor expertise to Audit & Finance oversight; financially literate membership and independent composition strengthen financial reporting and risk oversight .
  • Independence and conflicts: Board’s annual independence review and related-party policy found no transactions with related persons in fiscal 2024; Marren’s external role at Temasek is disclosed, with no related-party transactions identified and overall board independence affirmed (mitigates conflict concerns) .
  • Engagement and attendance: Meets attendance thresholds; participates in a board that holds regular executive sessions and maintains active investor engagement practices—supportive of investor confidence .
  • Pay alignment: 2024 mix of ~$120k cash and ~$238k equity aligns director interests with shareholders; RSU deferral election indicates long-term alignment; no perquisites, pensions, or options for directors; equity vests on one-year schedule with clearly defined change-of-control terms .

RED FLAGS

  • None identified in 2024 related-party transactions; no pledging; no director compensation anomalies disclosed. Temasek affiliation warrants ongoing monitoring for potential future transactions, but AMD’s Audit & Finance review framework and independence determination reduce risk of conflicts .